US-based OrbiMed closes fourth Asia-focused healthcare fund at $800m, surpasses target

US-based OrbiMed closes fourth Asia-focused healthcare fund at $800m, surpasses target

Photo from OrbiMed's website.

OrbiMed, a US-based life sciences investment firm, has closed its fourth Asia-focused healthcare fund after garnering $800 million in commitments, surpassing its $750 million target.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter